Bacterially Produced Recombinant Influenza Vaccines Based on Virus-Like Particles

• Andrea Jegerlehner,

  Affiliation Immunodrugs Department, Cytos Biotechnology AG, Schlieren, Zurich, Switzerland

  ⨯
• Franziska Zabel,

  Current address: Dermatology Department, University Hospital Zurich, Zurich, Switzerland

  Affiliation Immunodrugs Department, Cytos Biotechnology AG, Schlieren, Zurich, Switzerland

  ⨯
• Alice Langer,

  Affiliation Immunodrugs Department, Cytos Biotechnology AG, Schlieren, Zurich, Switzerland

  ⨯
• Klaus Dietmeier,

  Affiliation Immunodrugs Department, Cytos Biotechnology AG, Schlieren, Zurich, Switzerland

  ⨯
• Gary T. Jennings,

  Affiliation Immunodrugs Department, Cytos Biotechnology AG, Schlieren, Zurich, Switzerland

  ⨯
• Philippe Saudan ,

  * E-mail: philippe.saudan@cytos.com

  Affiliation Immunodrugs Department, Cytos Biotechnology AG, Schlieren, Zurich, Switzerland

  ⨯
• Martin F. Bachmann

  Current address: Dermatology Department, University Hospital Zurich, Zurich, Switzerland; Jenner Institute, Oxford, United Kingdom

  Affiliation Immunodrugs Department, Cytos Biotechnology AG, Schlieren, Zurich, Switzerland

  ⨯